Literature DB >> 1560225

Fetal-type phosphorylation of the tau in paired helical filaments.

K Kanemaru1, K Takio, R Miura, K Titani, Y Ihara.   

Abstract

To determine the phosphorylation sites of the tau in paired helical filaments (PHF), two types of PHF antisera with different specificities were used: One was a conventional anti-PHF, and the other was an antiserum to formic acid-denatured PHF (anti-HFoPHF). Phosphorylated tau-specific antibodies, anti-ptau 1 and anti-ptau 2, were prepared from anti-PHF and anti-HFoPHF, respectively. We found that both anti-ptau 1 and anti-ptau 2 labeled fetal or juvenile tau but not adult tau. The anti-ptau 1- and anti-ptau 2-recognition sites were immunochemically localized to the fragment Asp313 to Ile328 in the most COOH-terminal portion of tau. Furthermore, Ser315 was determined as the anti-ptau 2 recognition site. The sequence surrounding Ser315 was not found in the canonical sequences phosphorylated with known kinases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1560225     DOI: 10.1111/j.1471-4159.1992.tb10039.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  46 in total

Review 1.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases.

Authors:  Ritchie Williamson; Timothy Scales; Bruce R Clark; Graham Gibb; C Hugh Reynolds; Stuart Kellie; Ian N Bird; Ian M Varndell; Paul W Sheppard; Ian Everall; Brian H Anderton
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

3.  Neuronal and glial tau-positive inclusions in diverse neurologic diseases share common phosphorylation characteristics.

Authors:  T Iwatsubo; M Hasegawa; Y Ihara
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 4.  Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration.

Authors:  M L Billingsley; R L Kincaid
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

Review 5.  Biomarkers in Alzheimer's disease: past, present and future.

Authors:  Katarzyna Gustaw-Rothenberg; Alan Lerner; David J Bonda; Hyoung-gon Lee; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

6.  Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.

Authors:  A McShea; P L Harris; K R Webster; A F Wahl; M A Smith
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

7.  Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly.

Authors:  B L Goode; P E Denis; D Panda; M J Radeke; H P Miller; L Wilson; S C Feinstein
Journal:  Mol Biol Cell       Date:  1997-02       Impact factor: 4.138

8.  Activation of glycogen synthase kinase-3 induces Alzheimer-like tau hyperphosphorylation in rat hippocampus slices in culture.

Authors:  X Li; F Lu; Q Tian; Y Yang; Q Wang; J-Z Wang
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

9.  Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments.

Authors:  W K Liu; R T Williams; F L Hall; D W Dickson; S H Yen
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

Review 10.  Paired helical filament tau in Alzheimer's disease. The kinase connection.

Authors:  J Q Trojanowski; V M Lee
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.